 Kelly Sullivan
Concepts (275)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Down Syndrome | 19 | 2026 | 505 | 2.890 |
Why?
| | Tumor Suppressor Protein p53 | 11 | 2023 | 526 | 2.070 |
Why?
| | Proteome | 5 | 2025 | 483 | 1.110 |
Why?
| | Piperazines | 6 | 2023 | 371 | 0.890 |
Why?
| | Apoptosis | 14 | 2023 | 2571 | 0.880 |
Why?
| | Liposarcoma | 1 | 2023 | 26 | 0.810 |
Why?
| | Transcriptome | 7 | 2025 | 1007 | 0.790 |
Why?
| | Proto-Oncogene Proteins c-mdm2 | 5 | 2023 | 65 | 0.750 |
Why?
| | Interferons | 5 | 2023 | 195 | 0.750 |
Why?
| | Genes, p53 | 2 | 2012 | 68 | 0.730 |
Why?
| | Janus Kinase 1 | 1 | 2020 | 26 | 0.680 |
Why?
| | Janus Kinase 2 | 1 | 2020 | 32 | 0.680 |
Why?
| | Transcriptional Activation | 3 | 2022 | 377 | 0.670 |
Why?
| | Azetidines | 1 | 2020 | 46 | 0.670 |
Why?
| | Nuclear Proteins | 6 | 2017 | 716 | 0.640 |
Why?
| | Databases, Genetic | 1 | 2021 | 243 | 0.640 |
Why?
| | Neoplasms | 8 | 2023 | 2718 | 0.610 |
Why?
| | mRNA Cleavage and Polyadenylation Factors | 2 | 2009 | 27 | 0.600 |
Why?
| | Metabolome | 2 | 2025 | 366 | 0.590 |
Why?
| | Tumor Suppressor Proteins | 4 | 2018 | 325 | 0.560 |
Why?
| | GTPase-Activating Proteins | 2 | 2015 | 85 | 0.550 |
Why?
| | Ataxia Telangiectasia Mutated Proteins | 2 | 2015 | 70 | 0.540 |
Why?
| | Hypersensitivity | 1 | 2020 | 260 | 0.530 |
Why?
| | Imidazoles | 4 | 2023 | 254 | 0.520 |
Why?
| | Sulfonamides | 1 | 2020 | 565 | 0.500 |
Why?
| | Histones | 4 | 2009 | 638 | 0.500 |
Why?
| | Protein Kinase Inhibitors | 3 | 2020 | 917 | 0.480 |
Why?
| | Gene Expression Regulation, Neoplastic | 3 | 2018 | 1430 | 0.480 |
Why?
| | Antineoplastic Agents | 3 | 2023 | 2156 | 0.470 |
Why?
| | Caenorhabditis elegans Proteins | 2 | 2015 | 214 | 0.460 |
Why?
| | Isoquinolines | 1 | 2015 | 43 | 0.460 |
Why?
| | Mitochondrial Turnover | 1 | 2015 | 5 | 0.460 |
Why?
| | Immunity, Innate | 2 | 2020 | 852 | 0.430 |
Why?
| | DNA-Binding Proteins | 4 | 2017 | 1478 | 0.380 |
Why?
| | Cleavage And Polyadenylation Specificity Factor | 2 | 2009 | 11 | 0.380 |
Why?
| | Cell Cycle Proteins | 4 | 2023 | 632 | 0.370 |
Why?
| | Chromosomes, Human, Pair 21 | 2 | 2024 | 42 | 0.370 |
Why?
| | RNA, Messenger | 3 | 2020 | 2822 | 0.360 |
Why?
| | Reactive Oxygen Species | 1 | 2015 | 632 | 0.360 |
Why?
| | Proto-Oncogene Proteins c-met | 1 | 2012 | 72 | 0.360 |
Why?
| | Patient Selection | 1 | 2015 | 684 | 0.350 |
Why?
| | Fibroblasts | 1 | 2016 | 1017 | 0.340 |
Why?
| | Interferon-alpha | 3 | 2020 | 196 | 0.330 |
Why?
| | Gene Expression Profiling | 5 | 2024 | 1761 | 0.310 |
Why?
| | Cerebellar Neoplasms | 2 | 2022 | 179 | 0.300 |
Why?
| | Medulloblastoma | 2 | 2022 | 218 | 0.300 |
Why?
| | Active Transport, Cell Nucleus | 1 | 2009 | 122 | 0.290 |
Why?
| | Membrane Proteins | 1 | 2015 | 1156 | 0.280 |
Why?
| | Trisomy | 2 | 2019 | 78 | 0.270 |
Why?
| | Drosophila Proteins | 1 | 2009 | 206 | 0.260 |
Why?
| | Humans | 42 | 2025 | 140898 | 0.260 |
Why?
| | Signal Transduction | 7 | 2024 | 5148 | 0.260 |
Why?
| | Pyrimidines | 2 | 2024 | 508 | 0.260 |
Why?
| | HCT116 Cells | 3 | 2017 | 80 | 0.260 |
Why?
| | Biomarkers | 3 | 2022 | 4175 | 0.250 |
Why?
| | Inflammation | 1 | 2017 | 2891 | 0.250 |
Why?
| | Candidiasis, Oral | 1 | 2026 | 19 | 0.240 |
Why?
| | Animals | 19 | 2026 | 37579 | 0.240 |
Why?
| | Human Development | 1 | 2025 | 22 | 0.230 |
Why?
| | Janus Kinase Inhibitors | 1 | 2024 | 27 | 0.220 |
Why?
| | Mice | 13 | 2026 | 18057 | 0.220 |
Why?
| | Interferon-gamma | 2 | 2026 | 789 | 0.220 |
Why?
| | Datasets as Topic | 2 | 2022 | 123 | 0.220 |
Why?
| | Erythropoiesis | 1 | 2024 | 56 | 0.220 |
Why?
| | Cell Proliferation | 7 | 2023 | 2497 | 0.210 |
Why?
| | Heme | 1 | 2024 | 75 | 0.210 |
Why?
| | Proto-Oncogene Proteins | 4 | 2023 | 624 | 0.210 |
Why?
| | Autophagy | 2 | 2018 | 284 | 0.210 |
Why?
| | Receptors, Interferon | 2 | 2023 | 52 | 0.200 |
Why?
| | Activating Transcription Factor 4 | 1 | 2023 | 21 | 0.200 |
Why?
| | Proteasome Inhibitors | 1 | 2023 | 42 | 0.200 |
Why?
| | Glutamine | 1 | 2023 | 107 | 0.200 |
Why?
| | Piperidines | 1 | 2024 | 217 | 0.200 |
Why?
| | Protein Phosphatase 2C | 1 | 2022 | 15 | 0.200 |
Why?
| | Centrosome | 2 | 2023 | 71 | 0.190 |
Why?
| | Proto-Oncogene Proteins c-akt | 2 | 2015 | 442 | 0.190 |
Why?
| | Proteasome Endopeptidase Complex | 1 | 2023 | 159 | 0.190 |
Why?
| | Purines | 2 | 2020 | 182 | 0.190 |
Why?
| | Cell Line, Tumor | 7 | 2023 | 3487 | 0.180 |
Why?
| | Blood | 1 | 2022 | 113 | 0.180 |
Why?
| | Hedgehog Proteins | 2 | 2023 | 200 | 0.170 |
Why?
| | Autoimmunity | 3 | 2024 | 906 | 0.170 |
Why?
| | Cilia | 2 | 2023 | 172 | 0.170 |
Why?
| | Access to Information | 1 | 2021 | 45 | 0.170 |
Why?
| | Cell Death | 1 | 2022 | 387 | 0.170 |
Why?
| | Seroconversion | 1 | 2021 | 45 | 0.170 |
Why?
| | RNA Interference | 2 | 2015 | 468 | 0.160 |
Why?
| | Data Mining | 1 | 2021 | 115 | 0.160 |
Why?
| | Pyrazoles | 2 | 2022 | 480 | 0.160 |
Why?
| | Cytokines | 4 | 2024 | 2092 | 0.160 |
Why?
| | Cell Line | 5 | 2021 | 2879 | 0.160 |
Why?
| | RNA Helicases | 1 | 2020 | 31 | 0.160 |
Why?
| | Sex Characteristics | 1 | 2025 | 785 | 0.160 |
Why?
| | Toll-Like Receptors | 1 | 2020 | 189 | 0.160 |
Why?
| | Transcription, Genetic | 2 | 2017 | 1485 | 0.150 |
Why?
| | Case-Control Studies | 3 | 2022 | 3578 | 0.150 |
Why?
| | DNA Repair | 1 | 2021 | 239 | 0.150 |
Why?
| | Protein Domains | 2 | 2017 | 303 | 0.150 |
Why?
| | Molecular Sequence Data | 3 | 2015 | 2917 | 0.150 |
Why?
| | Kynurenine | 1 | 2019 | 115 | 0.150 |
Why?
| | Metabolomics | 2 | 2021 | 702 | 0.140 |
Why?
| | Young Adult | 5 | 2025 | 13646 | 0.140 |
Why?
| | Female | 15 | 2026 | 75540 | 0.140 |
Why?
| | Complement System Proteins | 2 | 2021 | 332 | 0.140 |
Why?
| | Forkhead Box Protein O3 | 1 | 2018 | 17 | 0.140 |
Why?
| | Proteomics | 2 | 2023 | 1136 | 0.140 |
Why?
| | Receptors, Growth Factor | 1 | 2017 | 56 | 0.140 |
Why?
| | RNA Precursors | 2 | 2009 | 156 | 0.140 |
Why?
| | Cell Cycle | 2 | 2012 | 598 | 0.130 |
Why?
| | Cyclin-Dependent Kinase 8 | 1 | 2017 | 51 | 0.130 |
Why?
| | T-Lymphocyte Subsets | 1 | 2019 | 414 | 0.130 |
Why?
| | Protein Biosynthesis | 1 | 2020 | 444 | 0.130 |
Why?
| | Apoptosis Regulatory Proteins | 1 | 2018 | 193 | 0.130 |
Why?
| | Leukemia, Biphenotypic, Acute | 1 | 2017 | 3 | 0.130 |
Why?
| | Caspases | 2 | 2015 | 245 | 0.130 |
Why?
| | Hypoxia | 1 | 2024 | 1164 | 0.130 |
Why?
| | Cell Cycle Checkpoints | 2 | 2020 | 97 | 0.130 |
Why?
| | Histidine Kinase | 1 | 2016 | 33 | 0.130 |
Why?
| | Antigens | 1 | 2018 | 361 | 0.120 |
Why?
| | Child, Preschool | 5 | 2025 | 11462 | 0.120 |
Why?
| | Down-Regulation | 2 | 2017 | 638 | 0.120 |
Why?
| | Male | 10 | 2025 | 69893 | 0.120 |
Why?
| | Enhancer Elements, Genetic | 1 | 2017 | 188 | 0.120 |
Why?
| | Proteolysis | 1 | 2017 | 173 | 0.120 |
Why?
| | Adult | 8 | 2025 | 39134 | 0.120 |
Why?
| | RNA-Binding Proteins | 1 | 2020 | 447 | 0.120 |
Why?
| | Colonic Neoplasms | 1 | 2018 | 244 | 0.120 |
Why?
| | Mice, Inbred C57BL | 4 | 2020 | 5895 | 0.120 |
Why?
| | Adenosine Triphosphatases | 1 | 2016 | 159 | 0.120 |
Why?
| | Genomics | 1 | 2021 | 810 | 0.120 |
Why?
| | BH3 Interacting Domain Death Agonist Protein | 1 | 2015 | 11 | 0.110 |
Why?
| | Heart Defects, Congenital | 1 | 2023 | 879 | 0.110 |
Why?
| | Pyrones | 1 | 2015 | 10 | 0.110 |
Why?
| | Caspase 8 | 1 | 2015 | 48 | 0.110 |
Why?
| | bcl-2-Associated X Protein | 1 | 2015 | 54 | 0.110 |
Why?
| | Cells, Cultured | 3 | 2018 | 4199 | 0.110 |
Why?
| | Azepines | 1 | 2015 | 97 | 0.110 |
Why?
| | Transcription Factors | 2 | 2022 | 1703 | 0.110 |
Why?
| | Repressor Proteins | 1 | 2017 | 428 | 0.110 |
Why?
| | Carrier Proteins | 1 | 2018 | 746 | 0.110 |
Why?
| | Morpholines | 1 | 2015 | 126 | 0.110 |
Why?
| | Sequence Homology, Amino Acid | 1 | 2015 | 391 | 0.110 |
Why?
| | Heat-Shock Proteins | 1 | 2015 | 141 | 0.110 |
Why?
| | Aminobenzoates | 1 | 2013 | 7 | 0.100 |
Why?
| | Fluorouracil | 1 | 2015 | 206 | 0.100 |
Why?
| | Base Sequence | 3 | 2020 | 2169 | 0.100 |
Why?
| | Proto-Oncogene Proteins c-bcl-2 | 1 | 2015 | 236 | 0.100 |
Why?
| | Carcinoma, Squamous Cell | 1 | 2018 | 640 | 0.100 |
Why?
| | Monocytes | 1 | 2016 | 578 | 0.100 |
Why?
| | Naphthalenes | 1 | 2013 | 59 | 0.100 |
Why?
| | Child | 6 | 2025 | 22313 | 0.100 |
Why?
| | Enzyme Activation | 1 | 2015 | 801 | 0.100 |
Why?
| | Ligands | 1 | 2015 | 667 | 0.100 |
Why?
| | Genes, Synthetic | 1 | 2012 | 14 | 0.100 |
Why?
| | Genes, Lethal | 1 | 2012 | 30 | 0.090 |
Why?
| | RNA, Small Interfering | 1 | 2015 | 624 | 0.090 |
Why?
| | Protein Structure, Tertiary | 1 | 2015 | 858 | 0.090 |
Why?
| | Liver | 1 | 2020 | 1815 | 0.090 |
Why?
| | Triple Negative Breast Neoplasms | 1 | 2015 | 199 | 0.090 |
Why?
| | Infant | 3 | 2025 | 9790 | 0.090 |
Why?
| | Adolescent | 5 | 2025 | 22027 | 0.090 |
Why?
| | Autoantigens | 2 | 2023 | 425 | 0.090 |
Why?
| | Chronic Disease | 1 | 2017 | 1811 | 0.090 |
Why?
| | Telomerase | 1 | 2013 | 247 | 0.090 |
Why?
| | Caenorhabditis elegans | 1 | 2014 | 332 | 0.080 |
Why?
| | Amino Acid Sequence | 1 | 2015 | 2152 | 0.080 |
Why?
| | Lipids | 1 | 2015 | 689 | 0.080 |
Why?
| | Hematopoiesis | 2 | 2021 | 193 | 0.080 |
Why?
| | Gene Expression Regulation | 2 | 2020 | 2604 | 0.080 |
Why?
| | Cleavage Stimulation Factor | 1 | 2009 | 4 | 0.080 |
Why?
| | Endonucleases | 1 | 2008 | 32 | 0.070 |
Why?
| | Middle Aged | 4 | 2025 | 34487 | 0.070 |
Why?
| | Mitochondria | 1 | 2015 | 974 | 0.070 |
Why?
| | Exoribonucleases | 1 | 2008 | 47 | 0.070 |
Why?
| | Mutation | 3 | 2015 | 3999 | 0.070 |
Why?
| | RNA Processing, Post-Transcriptional | 1 | 2008 | 91 | 0.070 |
Why?
| | Gene Knockdown Techniques | 1 | 2009 | 331 | 0.070 |
Why?
| | Multiprotein Complexes | 1 | 2009 | 171 | 0.070 |
Why?
| | T-Lymphocytes | 1 | 2016 | 2003 | 0.070 |
Why?
| | Disease Models, Animal | 3 | 2026 | 4407 | 0.070 |
Why?
| | Drosophila melanogaster | 1 | 2009 | 237 | 0.070 |
Why?
| | Candida albicans | 1 | 2026 | 57 | 0.060 |
Why?
| | Cell Nucleus | 1 | 2009 | 607 | 0.060 |
Why?
| | Breast Neoplasms | 1 | 2018 | 2235 | 0.060 |
Why?
| | Lung Neoplasms | 1 | 2018 | 2552 | 0.060 |
Why?
| | Disease Susceptibility | 1 | 2026 | 352 | 0.050 |
Why?
| | HeLa Cells | 3 | 2013 | 639 | 0.050 |
Why?
| | Glutamates | 1 | 2023 | 62 | 0.050 |
Why?
| | Pyrroles | 1 | 2024 | 209 | 0.050 |
Why?
| | Erythropoietin | 1 | 2024 | 98 | 0.050 |
Why?
| | Proline | 1 | 2023 | 80 | 0.050 |
Why?
| | Phenotype | 2 | 2023 | 3172 | 0.050 |
Why?
| | Eukaryotic Initiation Factor-2 | 1 | 2022 | 29 | 0.050 |
Why?
| | Centrioles | 1 | 2023 | 45 | 0.050 |
Why?
| | Growth Disorders | 1 | 2022 | 87 | 0.050 |
Why?
| | Hearing Loss, Sensorineural | 1 | 2022 | 68 | 0.050 |
Why?
| | G2 Phase Cell Cycle Checkpoints | 1 | 2022 | 44 | 0.050 |
Why?
| | Protein Binding | 2 | 2020 | 2238 | 0.040 |
Why?
| | Hypoalbuminemia | 1 | 2021 | 30 | 0.040 |
Why?
| | Binding Sites | 2 | 2014 | 1315 | 0.040 |
Why?
| | Stress, Physiological | 1 | 2024 | 452 | 0.040 |
Why?
| | Clonal Evolution | 1 | 2021 | 45 | 0.040 |
Why?
| | Seroepidemiologic Studies | 1 | 2021 | 167 | 0.040 |
Why?
| | Quinazolines | 1 | 2022 | 259 | 0.040 |
Why?
| | Insulin-Like Growth Factor I | 1 | 2022 | 318 | 0.040 |
Why?
| | Polyribosomes | 1 | 2020 | 24 | 0.040 |
Why?
| | Nucleotide Motifs | 1 | 2020 | 36 | 0.040 |
Why?
| | Quinolinic Acid | 1 | 2019 | 7 | 0.040 |
Why?
| | Biosynthetic Pathways | 1 | 2019 | 25 | 0.040 |
Why?
| | Proto-Oncogene Proteins c-myc | 1 | 2021 | 163 | 0.040 |
Why?
| | Indoleamine-Pyrrole 2,3,-Dioxygenase | 1 | 2019 | 57 | 0.040 |
Why?
| | 3' Untranslated Regions | 1 | 2020 | 149 | 0.040 |
Why?
| | Gene Silencing | 1 | 2020 | 197 | 0.040 |
Why?
| | Transforming Growth Factor beta2 | 1 | 2018 | 36 | 0.040 |
Why?
| | rhoA GTP-Binding Protein | 1 | 2018 | 82 | 0.040 |
Why?
| | Phosphorylation | 1 | 2022 | 1758 | 0.040 |
Why?
| | Glucose Transporter Type 3 | 1 | 2017 | 13 | 0.030 |
Why?
| | Phosphopyruvate Hydratase | 1 | 2017 | 27 | 0.030 |
Why?
| | Hexokinase | 1 | 2017 | 17 | 0.030 |
Why?
| | Complement Activation | 1 | 2021 | 415 | 0.030 |
Why?
| | Cell Lineage | 1 | 2019 | 351 | 0.030 |
Why?
| | Deoxyglucose | 1 | 2017 | 51 | 0.030 |
Why?
| | Inpatients | 1 | 2022 | 512 | 0.030 |
Why?
| | Cellular Senescence | 1 | 2019 | 206 | 0.030 |
Why?
| | MCF-7 Cells | 1 | 2017 | 126 | 0.030 |
Why?
| | Autoantibodies | 1 | 2024 | 1474 | 0.030 |
Why?
| | Ubiquitin-Conjugating Enzymes | 1 | 2017 | 13 | 0.030 |
Why?
| | Homeostasis | 1 | 2021 | 636 | 0.030 |
Why?
| | Neoplasm Proteins | 1 | 2020 | 433 | 0.030 |
Why?
| | Proteins | 1 | 2023 | 1013 | 0.030 |
Why?
| | Cell Hypoxia | 1 | 2017 | 231 | 0.030 |
Why?
| | Mutagenesis, Site-Directed | 1 | 2017 | 377 | 0.030 |
Why?
| | Gene Editing | 1 | 2017 | 86 | 0.030 |
Why?
| | Interleukin-1 Receptor-Associated Kinases | 1 | 2017 | 37 | 0.030 |
Why?
| | T-Lymphocytes, Regulatory | 1 | 2019 | 393 | 0.030 |
Why?
| | Cyclin-Dependent Kinases | 1 | 2017 | 130 | 0.030 |
Why?
| | Myeloid-Lymphoid Leukemia Protein | 1 | 2017 | 69 | 0.030 |
Why?
| | Tumor Cells, Cultured | 1 | 2018 | 956 | 0.030 |
Why?
| | Comorbidity | 1 | 2021 | 1658 | 0.030 |
Why?
| | Glycolysis | 1 | 2017 | 326 | 0.030 |
Why?
| | Lymphocyte Activation | 1 | 2019 | 1141 | 0.030 |
Why?
| | Flow Cytometry | 1 | 2019 | 1195 | 0.030 |
Why?
| | Tumor Protein p73 | 1 | 2015 | 18 | 0.030 |
Why?
| | Aurora Kinase A | 1 | 2015 | 55 | 0.030 |
Why?
| | Histone-Lysine N-Methyltransferase | 1 | 2017 | 134 | 0.030 |
Why?
| | Phosphatidylinositol Phosphates | 1 | 2014 | 39 | 0.030 |
Why?
| | Gene Expression | 1 | 2019 | 1490 | 0.030 |
Why?
| | Serine Proteases | 1 | 2013 | 19 | 0.030 |
Why?
| | Cell Movement | 1 | 2018 | 982 | 0.030 |
Why?
| | Models, Biological | 1 | 2021 | 1822 | 0.030 |
Why?
| | Protein Conformation | 1 | 2016 | 939 | 0.030 |
Why?
| | CD8-Positive T-Lymphocytes | 1 | 2019 | 915 | 0.020 |
Why?
| | Protein Transport | 1 | 2014 | 448 | 0.020 |
Why?
| | Interleukin-1 | 1 | 2017 | 972 | 0.020 |
Why?
| | Phosphatidylinositol 3-Kinases | 1 | 2014 | 368 | 0.020 |
Why?
| | Chromatin | 1 | 2016 | 533 | 0.020 |
Why?
| | Telomere-Binding Proteins | 1 | 2013 | 120 | 0.020 |
Why?
| | Cell Differentiation | 1 | 2019 | 1999 | 0.020 |
Why?
| | Xenograft Model Antitumor Assays | 1 | 2015 | 903 | 0.020 |
Why?
| | Hospitalization | 1 | 2021 | 2261 | 0.020 |
Why?
| | Biomarkers, Tumor | 1 | 2017 | 1243 | 0.020 |
Why?
| | Cell Survival | 1 | 2013 | 1129 | 0.020 |
Why?
| | Ribonucleoprotein, U7 Small Nuclear | 1 | 2008 | 1 | 0.020 |
Why?
| | Phosphorus Radioisotopes | 1 | 2008 | 27 | 0.020 |
Why?
| | Glyceraldehyde-3-Phosphate Dehydrogenase (Phosphorylating) | 1 | 2008 | 16 | 0.020 |
Why?
| | Regulatory Sequences, Nucleic Acid | 1 | 2008 | 92 | 0.020 |
Why?
| | Nucleotides | 1 | 2008 | 127 | 0.020 |
Why?
| | Substrate Specificity | 1 | 2008 | 384 | 0.020 |
Why?
| | Phosphates | 1 | 2008 | 179 | 0.020 |
Why?
| | RNA Stability | 1 | 2008 | 116 | 0.020 |
Why?
| | RNA | 1 | 2014 | 929 | 0.020 |
Why?
| | Drosophila | 1 | 2008 | 154 | 0.020 |
Why?
| | Genetic Vectors | 1 | 2006 | 336 | 0.010 |
Why?
| | Genotype | 1 | 2006 | 1862 | 0.010 |
Why?
| | DNA | 1 | 2006 | 1438 | 0.010 |
Why?
|
|
Sullivan's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|